and/or

46 Blog posts found

In the Lab

CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level

What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.

CAR T cells attacking cancer

Feature

T Is for T Cell: The Science Behind Immunotherapy

By deciphering the biology of T cells, MSK scientists gave immunotherapy a boost.

T cells on the loose.

Feature

6 Reasons to Come to MSK Monmouth for Your Cancer Care

Discover Memorial Sloan Kettering Monmouth, our newest outpatient center in Middletown Township, New Jersey.

In the Clinic

Targeting Pancreatic Cancer: An Increased Focus on Developing New Clinical Trials

Pancreatic cancer is difficult to treat, but researchers are focused on developing treatments that are personalized based on each individual patient’s disease.

In the Lab

Resistance Is Futile: Targeted Treatment Makes Stubborn Cancers Responsive to Immunotherapy

New research on an experimental drug provides hope for better responses to immunotherapy.

A chess match

Feature

Do Cancer Vaccines Have a Shot at Success?

After a string of failures, therapeutic cancer vaccines have acquired something of a bad rap. Can we do better?

Needle entering a vaccine vial.

Snapshot

T Cell Attack: Taking Down Cancer with Immunotherapy

MSK physician-scientist Prasad Adusumilli is focused on developing more-effective immunotherapy approaches for treating tumors in the chest.

Cell Therapy and Cell Engineering Facility

Finding

Gene Discovery Could Lead to More-Personalized Treatment with Immunotherapy

Researchers have found two gene mutations that many exceptional responders to ipilimumab have in common.

Nadeem Riaz and Timothy Chan

Feature

Radiation as Weapon and Cancer Cure: MSK Doctor Unearths Surprising History

An effort to develop a radiation test after 9/11 inspires a trip through medical history.

Total body irradiation unit at Memorial Hospital circa 1931

Q&A

Immunotherapy Offers New Strategy for Treating Sarcoma

Some of the first clinical trials testing immunotherapy for the treatment of sarcoma are now under way at MSK. Here’s a snapshot of where the research stands.

Enlarged microscopic image of blue-green immune cells surrounding one blue cancer cell.